Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Current Assets (2018 - 2025)

Historic Current Assets for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $684.5 million.

  • 10x Genomics' Current Assets rose 1712.29% to $684.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $684.5 million, marking a year-over-year increase of 1712.29%. This contributed to the annual value of $684.5 million for FY2025, which is 1712.29% up from last year.
  • Per 10x Genomics' latest filing, its Current Assets stood at $684.5 million for Q4 2025, which was up 1712.29% from $659.8 million recorded in Q3 2025.
  • Over the past 5 years, 10x Genomics' Current Assets peaked at $757.2 million during Q2 2021, and registered a low of $562.3 million during Q3 2023.
  • For the 5-year period, 10x Genomics' Current Assets averaged around $643.5 million, with its median value being $632.2 million (2022).
  • The largest annual percentage gain for 10x Genomics' Current Assets in the last 5 years was 7353.05% (2021), contrasted with its biggest fall of 1736.32% (2021).
  • 10x Genomics' Current Assets (Quarter) stood at $747.6 million in 2021, then decreased by 15.06% to $635.0 million in 2022, then decreased by 6.14% to $596.0 million in 2023, then fell by 1.95% to $584.4 million in 2024, then grew by 17.12% to $684.5 million in 2025.
  • Its Current Assets stands at $684.5 million for Q4 2025, versus $659.8 million for Q3 2025 and $655.7 million for Q2 2025.